Emma Culver

4.2k total citations
86 papers, 1.6k citations indexed

About

Emma Culver is a scholar working on Surgery, Rheumatology and Epidemiology. According to data from OpenAlex, Emma Culver has authored 86 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Surgery, 47 papers in Rheumatology and 42 papers in Epidemiology. Recurrent topics in Emma Culver's work include IgG4-Related and Inflammatory Diseases (46 papers), Liver Diseases and Immunity (31 papers) and Neuroendocrine Tumor Research Advances (26 papers). Emma Culver is often cited by papers focused on IgG4-Related and Inflammatory Diseases (46 papers), Liver Diseases and Immunity (31 papers) and Neuroendocrine Tumor Research Advances (26 papers). Emma Culver collaborates with scholars based in United Kingdom, Netherlands and United States. Emma Culver's co-authors include Eleanor Barnes, Roger W. Chapman, Adrian C Bateman, Tamsin Cargill, Mateusz Makuch, Ross Sadler, Berne Ferry, Anthony McIntyre, Theo Rispens and Simon Travis and has published in prestigious journals such as SHILAP Revista de lepidopterología, Hepatology and Gut.

In The Last Decade

Emma Culver

73 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Emma Culver United Kingdom 22 926 891 848 348 199 86 1.6k
Alexander C. Poen Netherlands 21 648 0.7× 1.3k 1.4× 624 0.7× 700 2.0× 434 2.2× 37 1.9k
María‐Carlota Londoño Spain 28 159 0.2× 720 0.8× 1.7k 2.0× 2.2k 6.4× 173 0.9× 125 2.9k
Türkan Terkivatan Netherlands 25 93 0.1× 996 1.1× 595 0.7× 1.1k 3.1× 504 2.5× 64 2.1k
Young Sook Park South Korea 19 116 0.1× 392 0.4× 425 0.5× 64 0.2× 174 0.9× 83 1.1k
Colin Tang Hong Kong 18 1.1k 1.2× 117 0.1× 432 0.5× 669 1.9× 156 0.8× 29 2.1k
Joshua I.S. Bleier United States 21 185 0.2× 724 0.8× 119 0.1× 101 0.3× 306 1.5× 44 1.5k
Zhishen Ye United States 16 446 0.5× 264 0.3× 232 0.3× 149 0.4× 901 4.5× 21 1.5k
José M. Enríquez–Navascués Spain 22 261 0.3× 807 0.9× 295 0.3× 330 0.9× 242 1.2× 132 1.6k
Raphael J. DeHoratius United States 19 722 0.8× 127 0.1× 146 0.2× 87 0.3× 153 0.8× 42 1.3k
Tommaso Maria Manzia Italy 24 62 0.1× 814 0.9× 539 0.6× 804 2.3× 121 0.6× 111 1.8k

Countries citing papers authored by Emma Culver

Since Specialization
Citations

This map shows the geographic impact of Emma Culver's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emma Culver with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emma Culver more than expected).

Fields of papers citing papers by Emma Culver

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emma Culver. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emma Culver. The network helps show where Emma Culver may publish in the future.

Co-authorship network of co-authors of Emma Culver

This figure shows the co-authorship network connecting the top 25 collaborators of Emma Culver. A scholar is included among the top collaborators of Emma Culver based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emma Culver. Emma Culver is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
High, Juliet, Matthew Hammond, Lee Shepstone, et al.. (2025). Assessing brodalumab in the treatment of primary sclerosing cholangitis (SABR-PSC pilot study): protocol for a single-arm, multicentre, pilot study. BMJ Open Gastroenterology. 12(1). e001596–e001596.
2.
Abbas, Nadir, Rachel A. Smith, Neil Halliday, et al.. (2025). Non‐Response to Obeticholic Acid Is Associated With Heightened Risks of Developing Clinical Events in Primary Biliary Cholangitis. Alimentary Pharmacology & Therapeutics. 63(4). 494–506.
3.
Mol, Bregje, et al.. (2025). Epidemiological and economical burden of cholestatic liver disease. Hepatology. 82(4). 813–833. 1 indexed citations
4.
Culver, Emma, Thien Ngoc Nguyen, Carol J. Cardona, et al.. (2024). Quantitative and qualitative analysis of stability for 16 serum immunoregulators over 50 freeze–thaw cycles. American Journal of Human Biology. 36(9). e24087–e24087. 1 indexed citations
5.
Lanzillotta, Marco, Emma Culver, Amita Sharma, et al.. (2024). Fibrotic phenotype of IgG4-related disease. The Lancet Rheumatology. 6(7). e469–e480. 20 indexed citations
6.
Henry, John A., Emmanuel Selvaraj, Matthew K. Burrage, et al.. (2023). Investigating the cardiac manifestations of IgG4-related disease using cardiac magnetic resonance imaging. European Heart Journal. 44(Supplement_2).
7.
Fernández‐Codina, Andreu, Marco Lanzillotta, Mikaël Ebbo, et al.. (2023). Development of an algorithm for IgG4-related disease management. Autoimmunity Reviews. 22(3). 103273–103273. 13 indexed citations
8.
Heneghan, Michael A., Elizabeth Shumbayawonda, Andrea Dennis, et al.. (2022). Quantitative magnetic resonance imaging to aid clinical decision making in autoimmune hepatitis. EClinicalMedicine. 46. 101325–101325. 17 indexed citations
9.
Shumbayawonda, Elizabeth, et al.. (2022). LiverMultiScan as an alternative to liver biopsy to monitor autoimmune hepatitis in the National Health Service in England: an economic evaluation. BMJ Open. 12(9). e058999–e058999. 6 indexed citations
10.
Ramirez, Giuseppe A., Marco Lanzillotta, Mikaël Ebbo, et al.. (2021). Clinical features and outcomes of COVID-19 in patients with IgG4-related disease: a European multi-centre study. Lara D. Veeken. 61(5). e109–e111. 5 indexed citations
11.
Chapman, Roger W., et al.. (2020). Review of primary sclerosing cholangitis with increased IgG4 levels. World Journal of Gastroenterology. 26(23). 3126–3144. 31 indexed citations
12.
Selvaraj, Emmanuel, Emma Culver, Helen Bungay, et al.. (2019). Evolving role of magnetic resonance techniques in primary sclerosing cholangitis. World Journal of Gastroenterology. 25(6). 644–658. 10 indexed citations
13.
Corcoran, John, Emma Culver, Tamsin Cargill, et al.. (2017). Thoracic involvement in IgG4-related disease in a UK-based patient cohort. Respiratory Medicine. 132. 117–121. 22 indexed citations
14.
Culver, Emma & Jonathan Booth. (2016). Choosing the correct path: the double orifice papilla. Gastrointestinal Endoscopy. 84(2). 378–379.
15.
Culver, Emma, Ellen Vermeulen, Mateusz Makuch, et al.. (2015). Increased IgG4 responses to multiple food and animal antigens indicate a polyclonal expansion and differentiation of pre-existing B cells in IgG4-related disease. Annals of the Rheumatic Diseases. 74(5). 944–947. 34 indexed citations
16.
Huggett, Matthew T., Emma Culver, Manoj Kumar, et al.. (2014). Type 1 Autoimmune Pancreatitis and IgG4-Related Sclerosing Cholangitis Is Associated With Extrapancreatic Organ Failure, Malignancy, and Mortality in a Prospective UK Cohort. The American Journal of Gastroenterology. 109(10). 1675–1683. 161 indexed citations
17.
Bateman, Adrian C, Emma Culver, Matthew Sommerlad, & Runjan Chetty. (2013). Intraduct papillary mucinous neoplasm of the pancreas: a tumour linked with IgG4-related disease?. Journal of Clinical Pathology. 66(8). 671–675. 17 indexed citations
18.
Culver, Emma, Kate D. Williamson, John Halliday, et al.. (2012). Elevated serum and tissue levels of IgG4 in Primary Sclerosing Cholangitis are associated with a worse clinical outcome. Hepatology. 56. 1 indexed citations
19.
Culver, Emma & Anthony McIntyre. (2011). Sporadic duodenal polyps: classification, investigation, and management. Endoscopy. 43(2). 144–155. 52 indexed citations
20.
Culver, Emma & Simon Travis. (2010). How to Manage the Infectious Risk under Anti-TNF in Inflammatory Bowel Disease. Current Drug Targets. 11(2). 198–218. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alexander C. Poen Breakdown of academic impact, for papers by María‐Carlota Londoño Breakdown of academic impact, for papers by Türkan Terkivatan Breakdown of academic impact, for papers by Young Sook Park Breakdown of academic impact, for papers by Colin Tang Breakdown of academic impact, for papers by Joshua I.S. Bleier Breakdown of academic impact, for papers by Zhishen Ye Breakdown of academic impact, for papers by José M. Enríquez–Navascués Breakdown of academic impact, for papers by Raphael J. DeHoratius Breakdown of academic impact, for papers by Tommaso Maria Manzia
Rankless by CCL
2026